News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Exciting lecture on "Superselective Intraarterial Cerebral Infusion of Bevacizumab (Avastin)" to be presented at CNJBTSG meeting this Thursday


Posted on: 07/31/2012

Exciting lecture to be presented at CNJBTSG meeting this Thursday :

 

John A. Boockvar, MD
Associate Professor of Neurosurgery
Co-Director, Surgical
Neuro-oncology
Director, Brain Tumor and Stem Cell Laboratory
Weill Cornell Medical College
New York/Presbyterian Hospital
Will be speaking about a new way to use Avastin for brain tumors: Super Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin). This experimental technique allows a much higher dose of Avastin to where it is needed.
It will be presented at the Central NJ Brain Tumor Support Group Meeting

  When:  Thursday August 2, 2012

   Time 7:00 P.M. - 8:30 P.M.

        Location NJ Neuroscience Center at JFK Medical Center, 65 James St, Edison, NJ 08818

 

There is no charge, but space is limited.  Please respond to this (musella@virtualtrials.com) if you want to attend. Tell me how many people you will be bringing.  

 

 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740